Manuel Constenla
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
- HER2/EGFR in Cancer Research
Papers in
- Oncology 40
- Colorectal Cancer Treatments and Studies 15
- Neutropenia and Cancer Infections 12
- Cancer Treatment and Pharmacology 10
-
- Lung Cancer Treatments and Mutations 14
- Gastric Cancer Management and Outcomes 9
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Alejandro MajlisVladimir MoiseyenkoC. BoniJaffer A. AjaniEric Van CutsemYee ChaoAdriano RodriguesM Fodor
- Journals
- Journal of Clinical Oncology (13 papers)Cancer (4 papers)Lung Cancer (4 papers)Clinical & Translational Oncology (3 papers)Annals of Oncology (3 papers)
- Partner nations
- SpainGermanyUnited Kingdom
In The Last Decade
Manuel Constenla
53 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Gastroenterology 591
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 2.2k
- Otorhinolaryngology 113
- Surgery 909
Countries citing papers authored by Manuel Constenla
This map shows the geographic impact of Manuel Constenla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Constenla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Constenla more than expected).
Fields of papers citing papers by Manuel Constenla
This network shows the impact of papers produced by Manuel Constenla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Constenla. The network helps show where Manuel Constenla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manuel Constenla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 8 | |
| 2 | 2018 | 20 | |
| 3 | 2017 | 10 | |
| 4 | 2016 | 1 | |
| 5 | 2016 | 5 | |
| 6 | 2014 | 1 | |
| 7 | 2010 | 18 | |
| 8 | 2010 | 45 | |
| 9 | 2008 | 79 | |
| 10 | 2007 | 33 | |
| 11 | 2006 | 46 | |
| 12 | 2005 | 139 | |
| 13 | 2005 | 13 | |
| 14 | 2004 | 42 | |
| 15 | 2003 | 5 | |
| 16 | 2002 | 3 | |
| 17 | 2002 | 11 | |
| 18 | 2001 | 12 | |
| 19 | 2000 | 30 | |
| 20 | 1999 | 2 |
About Manuel Constenla
Manuel Constenla is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hepatology and Dermatology, having authored 53 papers that have together received 3.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Lung Cancer Treatments and Mutations (14 papers), Neutropenia and Cancer Infections (12 papers), Cancer Treatment and Pharmacology (10 papers), Gastric Cancer Management and Outcomes (9 papers), Lung Cancer Diagnosis and Treatment (6 papers), Breast Cancer Treatment Studies (5 papers) and Blood disorders and treatments (4 papers). The work is most often cited by research in Gastroenterology (591 citations), Oncology (2.0k citations), Pulmonary and Respiratory Medicine (2.2k citations), Otorhinolaryngology (113 citations) and Surgery (909 citations). Manuel Constenla has collaborated with scholars based in Spain, Germany and United Kingdom. Frequent co-authors include Alejandro Majlis, Vladimir Moiseyenko, C. Boni, Jaffer A. Ajani, Eric Van Cutsem, Yee Chao, Adriano Rodrigues, M Fodor, Э К Возный and Sergei Tjulandin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Lung Cancer, Clinical & Translational Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.